{"disease":{"id":"ovarian-gynandroblastoma","name":"ovarian gynandroblastoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03382158","title":"International PPB/DICER1 Registry","phase":"","overall_status":"RECRUITING","enrollment_count":3400,"lead_sponsor_name":"Children's Hospitals and Clinics of Minnesota","has_results":false},{"nct_id":"NCT01042522","title":"Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":63,"lead_sponsor_name":"GOG Foundation","has_results":true},{"nct_id":"NCT00748657","title":"Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT00006227","title":"Paclitaxel in Treating Patients With Ovarian Stromal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Gynecologic Oncology Group","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}